Productivity cost model of the treatment of rheumatoid arthritis with abatacept

Journal of Medical Economics

Volumn 11, Issue 1, 2008, Pages 3-21

  Burton, Wayne N ^a   Morrison, Alan ^b   Yuan, Yong ^c   Li, Tracy ^c   Marioni, Riccardo E ^d   Maclean, Ross ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SCRIBCO   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Absenteeism; Antirheumatic agents; Economics; Rheumatoid arthritis

Indexed keywords

ABATACEPT;

ABSENTEEISM; ADULT; ARTICLE; COST; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; ECONOMIC ASPECT; EMPLOYEE; FEMALE; HUMAN; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRODUCTIVITY; RHEUMATOID ARTHRITIS;

ABSENTEEISM; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CAREGIVERS; COSTS AND COST ANALYSIS; EFFICIENCY; FEMALE; HUMANS; IMMUNOCONJUGATES; MALE; MODELS, ECONOMETRIC; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UNITED STATES;

EID: 42949113969     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990701748837     Document Type: Article

References (66)